300298 三诺生物
午间休市 08-07 11:30:00
资讯
新帖
简况
研报掘金丨浙商证券:维持三诺生物“增持”评级,境内业务发展强劲
格隆汇 · 08-06 15:23
研报掘金丨浙商证券:维持三诺生物“增持”评级,境内业务发展强劲
股市必读:三诺生物新发布《2026年半年度报告摘要》
证券之星 · 08-05 01:48
股市必读:三诺生物新发布《2026年半年度报告摘要》
三诺生物(300298)6月30日股东户数2.31万户,较上期减少8.68%
证券之星 · 08-04 17:51
三诺生物(300298)6月30日股东户数2.31万户,较上期减少8.68%
三诺生物(300298)披露2026年半年度报告,8月3日股价上涨1.22%
证券之星 · 08-03
三诺生物(300298)披露2026年半年度报告,8月3日股价上涨1.22%
三诺生物(300298.SZ)发布半年度业绩,归母净利润2.21亿元,同比增长22.52%
智通财经 · 08-03
三诺生物(300298.SZ)发布半年度业绩,归母净利润2.21亿元,同比增长22.52%
股市必读:三诺生物(300298)新发布《关于取得医疗器械注册证暨医疗器械注册变更的公告》
证券之星 · 07-31
股市必读:三诺生物(300298)新发布《关于取得医疗器械注册证暨医疗器械注册变更的公告》
三诺生物(300298)披露取得医疗器械注册证暨注册变更公告,7月29日股价上涨2.12%
证券之星 · 07-29
三诺生物(300298)披露取得医疗器械注册证暨注册变更公告,7月29日股价上涨2.12%
三诺生物(300298)披露为全资子公司提供担保的进展公告,7月28日股价上涨0.52%
证券之星 · 07-28
三诺生物(300298)披露为全资子公司提供担保的进展公告,7月28日股价上涨0.52%
三诺生物(300298)披露预计触发可转债转股价格向下修正条件的提示性公告,7月27日股价上涨3.06%
证券之星 · 07-27
三诺生物(300298)披露预计触发可转债转股价格向下修正条件的提示性公告,7月27日股价上涨3.06%
三诺生物(300298)披露财务总监辞职暨聘任公告,7月24日股价下跌2.59%
证券之星 · 07-24
三诺生物(300298)披露财务总监辞职暨聘任公告,7月24日股价下跌2.59%
三诺生物获得实用新型专利授权:“一种试条插入位置检测装置”
证券之星 · 07-14
三诺生物获得实用新型专利授权:“一种试条插入位置检测装置”
三诺生物:正在积极探索CGM等检测技术在动物健康领域的应用可能
证券之星 · 07-10
三诺生物:正在积极探索CGM等检测技术在动物健康领域的应用可能
股市必读:三诺生物(300298)7月9日董秘有最新回复
证券之星 · 07-10
股市必读:三诺生物(300298)7月9日董秘有最新回复
三诺生物:持续优化产品外观设计与功能性
证券之星 · 07-09
三诺生物:持续优化产品外观设计与功能性
三诺生物(300298)披露产品通过创新医疗器械特别审查暨医疗器械注册变更公告,7月8日股价上涨0.07%
证券之星 · 07-08
三诺生物(300298)披露产品通过创新医疗器械特别审查暨医疗器械注册变更公告,7月8日股价上涨0.07%
三诺生物(300298)披露回购公司股份进展公告,7月1日股价上涨3.08%
证券之星 · 07-01
三诺生物(300298)披露回购公司股份进展公告,7月1日股价上涨3.08%
三诺生物:欧洲专利诉讼实体审理周期较长
证券之星 · 07-01
三诺生物:欧洲专利诉讼实体审理周期较长
三诺生物(300298)披露完成工商变更登记公告,6月16日股价下跌1.81%
证券之星 · 06-16
三诺生物(300298)披露完成工商变更登记公告,6月16日股价下跌1.81%
股市必读:三诺生物(300298)6月1日董秘有最新回复
证券之星 · 06-02
股市必读:三诺生物(300298)6月1日董秘有最新回复
三诺生物:公司自研的生物传感技术主要应用于糖尿病及相关慢性疾病的监测与管理
证券之星 · 06-01
三诺生物:公司自研的生物传感技术主要应用于糖尿病及相关慢性疾病的监测与管理
暂无数据
公司概况
公司名称:
三诺生物传感股份有限公司
所属行业:
专用设备制造业
上市日期:
2012-03-19
主营业务:
三诺生物传感股份有限公司的主营业务是血糖监测系统、糖化血红蛋白检测系统、血脂检测系统、血压计等生产和销售。公司的主要产品是家用医疗产品、等级医院专业产品、基层医疗专业产品、糖尿病医疗健康服务。公司作为血糖监测领域领先企业,相继获得国内外权威机构的高度认可和荣誉。荣获“国家企业技术中心”“国家工程研究中心”“国家技术创新示范企业”“国家知识产权优势企业”“国家科技进步二等奖”“国家绿色工厂”和“制造业单项冠军企业”等资质。
发行价格:
29.00
{"stockData":{"symbol":"300298","market":"SZ","secType":"STK","nameCN":"三诺生物","latestPrice":16.15,"timestamp":1786077159000,"preClose":16.16,"halted":0,"volume":3604400,"delay":0,"changeRate":-0.0006,"floatShares":448000000,"shares":557000000,"eps":0.2395,"marketStatus":"午间休市","change":-0.01,"latestTime":"08-07 11:30:00","open":16.14,"high":16.22,"low":15.91,"amount":57771900,"amplitude":0.0192,"askPrice":16.16,"askSize":4,"bidPrice":16.15,"bidSize":348,"shortable":0,"etf":0,"ttmEps":0.2395,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786078800000},"marketStatusCode":3,"adr":0,"adjPreClose":16.16,"symbolType":"stock","openAndCloseTimeList":[[1786066200000,1786073400000],[1786078800000,1786086000000]],"highLimit":17.78,"lowLimit":14.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":556845893,"isCdr":false,"pbRate":3.04,"roa":"--","peRate":67.43215,"roe":"7.02%","epsLYR":0.1685,"committee":-0.116908,"marketValue":8993000000,"turnoverRate":0.008,"status":1,"floatMarketCap":7235000000},"requestUrl":"/m/hq/s/300298/tweets","defaultTab":"tweets","newsList":[{"id":"2657688756","title":"研报掘金丨浙商证券:维持三诺生物“增持”评级,境内业务发展强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2657688756","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657688756?lang=zh_cn&edition=full","pubTime":"2026-08-06 15:23","pubTimestamp":1786001027,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0276","601878","300298","BK0102","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563547","title":"股市必读:三诺生物新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657563547?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:48","pubTimestamp":1785865697,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,三诺生物报收于16.18元,下跌2.24%,换手率2.74%,成交量12.27万手,成交额1.97亿元。公司公告汇总:三诺生物决定不向下修正“三诺转债”转股价格,并承诺2026年8月4日至12月20日期间不再修正。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0251","BK0114","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656312745","title":"三诺生物(300298)6月30日股东户数2.31万户,较上期减少8.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656312745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656312745?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:51","pubTimestamp":1785837081,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三诺生物披露,截至2026年6月30日公司股东户数为2.31万户,较3月31日减少2194.0户,减幅为8.68%。在医疗器械行业个股中,三诺生物股东户数高于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.14万户。从股价来看,2026年3月31日至2026年6月30日,三诺生物区间跌幅为12.1%,在此期间股东户数减少2194.0户,减幅为8.68%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400030037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","BK0102","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656774883","title":"三诺生物(300298)披露2026年半年度报告,8月3日股价上涨1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656774883","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656774883?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:30","pubTimestamp":1785767433,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,三诺生物报收于16.55元,较前一交易日上涨1.22%,最新总市值为92.16亿元。该股当日开盘16.35元,最高16.66元,最低16.31元,成交额达1.21亿元,换手率为1.64%。近日,三诺生物披露《2026年半年度报告》。报告显示,本报告期营业收入2,537,036,279.21元,同比增长12.08%;归属于上市公司股东的净利润221,337,341.60元,同比增长22.52%;扣除非经常性损益后的净利润210,299,160.14元,同比增长32.87%。总资产5,947,418,549.87元,较上年度末下降0.25%;归属于上市公司股东的净资产3,081,606,019.19元,同比下降1.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0102","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656632048","title":"三诺生物(300298.SZ)发布半年度业绩,归母净利润2.21亿元,同比增长22.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656632048","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656632048?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:14","pubTimestamp":1785752077,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三诺生物 发布2026年半年度报告,2026年上半年,公司实现营业收入25.37亿元,同比增长12.08%;归属于上市公司股东的净利润2.21亿元,同比增长22.52%;归属于上市公司股东的扣除非经常性损益的净利润2.1亿元,同比增长32.87%;基本每股收益0.4096元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三诺生物(300298.SZ)发布半年度业绩,归母净利润2.21亿元,同比增长22.52%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655490800","title":"股市必读:三诺生物(300298)新发布《关于取得医疗器械注册证暨医疗器械注册变更的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655490800","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655490800?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:46","pubTimestamp":1785437172,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,三诺生物报收于16.08元,上涨1.2%,换手率1.51%,成交量6.74万手,成交额1.08亿元。公司公告汇总关于取得医疗器械注册证暨医疗器械注册变更的公告三诺生物传感股份有限公司近日获得四项《医疗器械注册证》和两项《医疗器械变更注册(备案)文件》。其中,血脂检测仪为新获批产品,三项血糖试条为延续注册,血酮体试条和糖化血红蛋白检测试剂盒为变更注册,涉及产品名称、预期用途、技术要求、说明书等内容变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300298","09996","159883","BK1583","BK0102","BK1100","BK1574","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655389907","title":"三诺生物(300298)披露取得医疗器械注册证暨注册变更公告,7月29日股价上涨2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655389907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655389907?lang=zh_cn&edition=full","pubTime":"2026-07-29 22:40","pubTimestamp":1785336025,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘,三诺生物报收于15.89元,较前一交易日上涨2.12%,最新总市值为88.48亿元。该股当日开盘15.59元,最高15.95元,最低15.59元,成交额达1.08亿元,换手率为1.53%。近日,三诺生物传感股份有限公司获得四项《医疗器械注册证》和两项《医疗器械变更注册(备案)文件》。此次注册证的取得与变更有助于丰富公司产品线,满足多元化检测需求,但对经营业绩的影响存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900040755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","BK1100","BK0114","BK0251","09996","159883","BK0102","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654883394","title":"三诺生物(300298)披露为全资子公司提供担保的进展公告,7月28日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654883394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654883394?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:28","pubTimestamp":1785248899,"startTime":"0","endTime":"0","summary":"近日,三诺生物传感股份有限公司披露《关于为全资子公司提供担保的进展公告》。公告显示,公司于2026年7月28日与中信银行长沙分行签订《最高额保证合同》,为全资子公司长沙章风电子商务有限公司提供3,000万元连带责任保证担保,担保期限为主合同项下债务履行期限届满之日起三年。本次担保后,公司对章风电子的担保余额为3,000万元,占公司最近一期经审计净资产的0.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300298","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654046378","title":"三诺生物(300298)披露预计触发可转债转股价格向下修正条件的提示性公告,7月27日股价上涨3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654046378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654046378?lang=zh_cn&edition=full","pubTime":"2026-07-27 22:27","pubTimestamp":1785162433,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘,三诺生物报收于15.48元,较前一交易日上涨3.06%,最新总市值为86.2亿元。三诺生物传感股份有限公司于近日披露《关于预计触发可转债转股价格向下修正条件的提示性公告》。公告显示,公司证券简称三诺生物,债券简称三诺转债,当前转股价格为34.52元/股,转股期限为2021年6月25日至2026年12月20日。自2026年7月14日至7月27日,公司股票已有10个交易日收盘价低于当期转股价格的80%,预计将触发可转债转股价格向下修正条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700034970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0251","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033855","title":"三诺生物(300298)披露财务总监辞职暨聘任公告,7月24日股价下跌2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653033855?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:32","pubTimestamp":1784903542,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,三诺生物报收于15.02元,较前一交易日下跌2.59%,最新总市值为83.64亿元。该股当日开盘15.33元,最高15.46元,最低14.99元,成交额达9984.79万元,换手率为1.47%。公司于2026年7月24日召开第六届董事会第五次会议,审议通过聘任谈波先生为新任财务总监,任期至第六届董事会任期届满。谈波先生具备相关专业资质和任职条件,未持有公司股份,与主要股东无关联关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300298","BK0102","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651141566","title":"三诺生物获得实用新型专利授权:“一种试条插入位置检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2651141566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651141566?lang=zh_cn&edition=full","pubTime":"2026-07-14 03:42","pubTimestamp":1783971744,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示三诺生物新获得一项实用新型专利授权,专利名为“一种试条插入位置检测装置”,专利申请号为CN202521508589.6,授权日为2026年7月14日。今年以来三诺生物新获得专利授权30个,较去年同期增加了20%。通过天眼查大数据分析,三诺生物传感股份有限公司共对外投资了11家企业,参与招投标项目812次;财产线索方面有商标信息870条,专利信息632条,著作权信息183条;此外企业还拥有行政许可1516个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400004698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0102","300298","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650138879","title":"三诺生物:正在积极探索CGM等检测技术在动物健康领域的应用可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2650138879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650138879?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:52","pubTimestamp":1783687936,"startTime":"0","endTime":"0","summary":"证券之星消息,三诺生物07月09日在投资者关系平台上答复投资者关心的问题。在宠物医疗领域,公司基于在血糖监测特别是持续葡萄糖监测领域积累的技术经验,正在积极探索CGM等检测技术在动物健康领域的应用可能。未来,公司将在聚焦糖尿病及慢病管理主业的基础上,持续关注POCT检测技术在包括动物健康在内的更多场景的应用机会,并结合公司整体战略审慎评估相关业务拓展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000042061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0251","BK0114","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650976749","title":"股市必读:三诺生物(300298)7月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2650976749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650976749?lang=zh_cn&edition=full","pubTime":"2026-07-10 01:52","pubTimestamp":1783619532,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘,三诺生物报收于14.24元,下跌1.04%,换手率1.18%,成交量5.28万手,成交额7576.77万元。董秘最新回复投资者: 董秘你好,请问贵司是否考虑过升级佩戴式血糖监测仪产品的外观样式呢?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0251","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650404639","title":"三诺生物:持续优化产品外观设计与功能性","url":"https://stock-news.laohu8.com/highlight/detail?id=2650404639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650404639?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:21","pubTimestamp":1783588868,"startTime":"0","endTime":"0","summary":"证券之星消息,三诺生物07月09日在投资者关系平台上答复投资者关心的问题。公司高度重视产品用户体验,在产品设计方面,公司始终将用户佩戴体验作为核心考量,目前持续葡萄糖监测系统二代产品已通过优化尺寸和一体式植入设计提升佩戴的便捷性、舒适性。未来公司将结合市场需求,在确保医疗级精准度的前提下,持续优化产品外观设计与功能性,提升用户使用体验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","BK0102","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649994264","title":"三诺生物(300298)披露产品通过创新医疗器械特别审查暨医疗器械注册变更公告,7月8日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649994264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649994264?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:34","pubTimestamp":1783521260,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘,三诺生物报收于14.39元,较前一交易日上涨0.07%,最新总市值为80.13亿元。该股当日开盘14.41元,最高14.64元,最低14.21元,成交额达7462.96万元,换手率为1.16%。近日,三诺生物传感股份有限公司发布公告称,其产品“血糖血酮测试条”通过湖南省第二类创新医疗器械特别审查,有助于缩短注册周期、加快上市进度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800043003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0102","BK1583","159883","09996","BK1100","BK0114","BK0251","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654120","title":"三诺生物(300298)披露回购公司股份进展公告,7月1日股价上涨3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648654120?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:51","pubTimestamp":1782917471,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘,三诺生物报收于14.38元,较前一交易日上涨3.08%,最新总市值为80.07亿元。该股当日开盘13.9元,最高14.45元,最低13.85元,成交额达7666.13万元,换手率为1.21%。近日,三诺生物传感股份有限公司披露《关于回购公司股份的进展公告》。公告显示,公司于2026年3月27日召开第六届董事会第三次会议,2026年4月13日召开临时股东大会,审议通过回购公司股份方案。本次回购符合相关法律法规及公司回购方案的要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0102","BK0251","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648651494","title":"三诺生物:欧洲专利诉讼实体审理周期较长","url":"https://stock-news.laohu8.com/highlight/detail?id=2648651494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648651494?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:12","pubTimestamp":1782900723,"startTime":"0","endTime":"0","summary":"证券之星消息,三诺生物07月01日在投资者关系平台上答复投资者关心的问题。董秘.欧洲CGM专利诉讼什么时候有结果、二代CGM美国临床什么时候启动…同时,公司已于2026年3月3日向欧洲专利局提交了异议申请。后续如有重大进展,公司将严格按照监管规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100035592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","BK0102","300298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643030755","title":"三诺生物(300298)披露完成工商变更登记公告,6月16日股价下跌1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643030755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643030755?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:20","pubTimestamp":1781605201,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,三诺生物报收于14.65元,较前一交易日下跌1.81%,最新总市值为81.58亿元。三诺生物于近日披露《关于完成工商变更登记的公告》。公告显示,公司于2026年3月27日召开第六届董事会第三次会议,于2026年4月13日召开2026年第一次临时股东会,审议通过变更注册资本并修订《公司章程》的议案,注册资本由560,266,088元变更为556,845,806元。公司已办理完成工商变更登记手续,并取得长沙市市场监督管理局换发的新《营业执照》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0102","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969252","title":"股市必读:三诺生物(300298)6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640969252?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:43","pubTimestamp":1780339388,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,三诺生物报收于15.72元,上涨0.96%,换手率0.85%,成交量3.83万手,成交额5999.59万元。公司公告汇总关于第二期员工持股计划第五个锁定期届满的提示性公告三诺生物第二期员工持股计划第五个锁定期已于2026年5月31日届满,对应可解锁股份为590,162股,占公司当前总股本的0.11%。关于回购公司股份的进展公告三诺生物传感股份有限公司于2026年3月27日召开董事会,4月13日召开临时股东大会,审议通过回购公司股份方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","300298","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640953468","title":"三诺生物:公司自研的生物传感技术主要应用于糖尿病及相关慢性疾病的监测与管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640953468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640953468?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:30","pubTimestamp":1780309828,"startTime":"0","endTime":"0","summary":"证券之星消息,三诺生物06月01日在投资者关系平台上答复投资者关心的问题。公司自研的生物传感技术主要应用于糖尿病及相关慢性疾病的监测与管理,目前暂未涉及传感芯片其他领域的研发与应用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100030308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300298","BK0102","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786077196325,"stockEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.1238},{"period":"3month","weight":-0.0516},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.2286},{"period":"ytd","weight":-0.0555}],"compareEarnings":[{"period":"1week","weight":0.0251},{"period":"1month","weight":-0.0225},{"period":"3month","weight":-0.0669},{"period":"6month","weight":-0.0406},{"period":"1year","weight":0.0733},{"period":"ytd","weight":-0.0173}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"三诺生物传感股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"23087人(较上一季度减少8.68%)","perCapita":"19404股","listingDate":"2012-03-19","address":"湖南省长沙市岳麓区高新技术产业开发区谷苑路265号;湖南省长沙市岳麓区青山西路11号","registeredCapital":"55684万元","survey":" 三诺生物传感股份有限公司的主营业务是血糖监测系统、糖化血红蛋白检测系统、血脂检测系统、血压计等生产和销售。公司的主要产品是家用医疗产品、等级医院专业产品、基层医疗专业产品、糖尿病医疗健康服务。公司作为血糖监测领域领先企业,相继获得国内外权威机构的高度认可和荣誉。荣获“国家企业技术中心”“国家工程研究中心”“国家技术创新示范企业”“国家知识产权优势企业”“国家科技进步二等奖”“国家绿色工厂”和“制造业单项冠军企业”等资质。","listedPrice":29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三诺生物,300298,三诺生物股票,三诺生物股票老虎,三诺生物股票老虎国际,三诺生物行情,三诺生物股票行情,三诺生物股价,三诺生物股市,三诺生物股票价格,三诺生物股票交易,三诺生物股票购买,三诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}